A role for PKCzeta in potentiation of the topoisomerase II activity and etoposide cytotoxicity by wortmannin

Mol Cancer Ther. 2005 Oct;4(10):1457-64. doi: 10.1158/1535-7163.MCT-05-0156.

Abstract

Enhanced cytotoxicity of etoposide by wortmannin, an inhibitor of enzymes holding a phosphatidylinositol 3-kinase domain, was investigated in eight cell lines proficient or deficient for DNA double-strand break repair. Wortmannin stimulated the decatenating activity of topoisomerase II, promoted etoposide-induced accumulation of DNA double-strand breaks, shifted the specificity for cell killing by etoposide from the S to G1 phase of the cell cycle, and potentiated the cytotoxicity of etoposide through two mechanisms. (a) Sensitization to high, micromolar amounts of etoposide required integrity of the nonhomologous end-joining repair pathway. (b) Wortmannin dramatically increased the susceptibility to low, submicromolar amounts of etoposide in a large fraction of the cell population irrespective of the status of ATM, Ku86, and DNA-PKCS. It is shown that this process correlates depression of phosphatidylinositol 3-kinase-dependent phosphorylation of the atypical, zeta isoform of protein kinase C (PKCzeta). Stable expression of a dominant-negative, kinase-dead mutant of PKCzeta in a tumor cell line reproduced the hypersensitivity pattern induced by wortmannin. The results are consistent with up-regulation of the topoisomerase II activity in relation to inactivation of PKCzeta and indicate that PKCzeta may be a useful target to improve the efficiency of topoisomerase II poisons at low concentration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androstadienes / pharmacology*
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology*
  • Cell Cycle / drug effects
  • Cell Line
  • Cell Line, Tumor
  • Cricetinae
  • Cricetulus
  • DNA Topoisomerases, Type II / metabolism*
  • Drug Synergism
  • Etoposide / pharmacology*
  • HeLa Cells
  • Humans
  • Mice
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation / drug effects
  • Protein Kinase C / genetics
  • Protein Kinase C / metabolism*
  • Protein Kinase Inhibitors / pharmacology
  • Rabbits
  • Topoisomerase II Inhibitors
  • Transfection
  • U937 Cells
  • Wortmannin

Substances

  • Androstadienes
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors
  • Topoisomerase II Inhibitors
  • Etoposide
  • protein kinase C zeta
  • Protein Kinase C
  • DNA Topoisomerases, Type II
  • Wortmannin